TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 221 filers reported holding TRANSMEDICS GROUP INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,386,351 | -42.9% | 536,737 | -12.4% | 0.47% | -35.6% |
Q2 2023 | $51,447,240 | +7.9% | 612,613 | -2.7% | 0.73% | +6.1% |
Q1 2023 | $47,670,823 | +13.2% | 629,484 | -7.7% | 0.69% | +23.8% |
Q4 2022 | $42,096,620 | +54.3% | 682,058 | +4.3% | 0.56% | +42.6% |
Q3 2022 | $27,290,000 | +49.6% | 653,814 | +12.7% | 0.39% | +51.9% |
Q2 2022 | $18,237,000 | +16.5% | 579,887 | -0.2% | 0.26% | +41.8% |
Q1 2022 | $15,653,000 | +40.6% | 581,029 | 0.0% | 0.18% | +58.3% |
Q4 2021 | $11,133,000 | -42.1% | 581,029 | 0.0% | 0.12% | -41.0% |
Q3 2021 | $19,226,000 | -20.6% | 581,029 | -20.4% | 0.20% | -17.4% |
Q2 2021 | $24,221,000 | -21.3% | 729,989 | -1.6% | 0.24% | -27.6% |
Q1 2021 | $30,794,000 | +141.2% | 742,200 | +15.7% | 0.33% | +123.3% |
Q4 2020 | $12,768,000 | +60.5% | 641,612 | +11.2% | 0.15% | +32.7% |
Q3 2020 | $7,953,000 | +4.4% | 577,147 | +35.8% | 0.11% | +1.9% |
Q2 2020 | $7,616,000 | – | 425,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Divisadero Street Capital Management, LP | 325,000 | $27,293,500 | 7.89% |
Ophir Asset Management Pty Ltd | 418,366 | $35,134,377 | 7.32% |
Sandhill Capital Partners LLC | 812,844 | $68,262,667 | 6.22% |
Kent Lake Capital LLC | 119,129 | $10,004,453 | 4.60% |
Eagle Health Investments LP | 232,032 | $19,486,047 | 3.64% |
NEXT CENTURY GROWTH INVESTORS LLC | 442,942 | $37,198,269 | 3.58% |
Bullseye Asset Management LLC | 83,012 | $6,971 | 3.50% |
First Light Asset Management, LLC | 377,464 | $31,699,427 | 2.48% |
Nicholas Investment Partners, LP | 367,631 | $30,873,651 | 2.11% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 671,716 | $56,410,710 | 2.09% |